Structural basis of ligand interaction with atypical chemokine receptor 3

Martin Gustavsson, Liwen Wang, Noortje van Gils, Bryan S. Stephens, Penglie Zhang, Thomas J. Schall, Sichun Yang, Ruben Abagyan, Mark R. Chance (), Irina Kufareva () and Tracy M. Handel ()
Additional contact information
Martin Gustavsson: Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California, San Diego
Liwen Wang: Case Western Reserve University School of Medicine
Noortje van Gils: Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California, San Diego
Bryan S. Stephens: Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California, San Diego
Penglie Zhang: ChemoCentryx Inc.
Thomas J. Schall: ChemoCentryx Inc.
Sichun Yang: Case Western Reserve University School of Medicine
Ruben Abagyan: Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California, San Diego
Mark R. Chance: Case Western Reserve University School of Medicine
Irina Kufareva: Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California, San Diego
Tracy M. Handel: Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California, San Diego

Nature Communications, 2017, vol. 8, issue 1, 1-14

Abstract: Abstract Chemokines drive cell migration through their interactions with seven-transmembrane (7TM) chemokine receptors on cell surfaces. The atypical chemokine receptor 3 (ACKR3) binds chemokines CXCL11 and CXCL12 and signals exclusively through β-arrestin-mediated pathways, without activating canonical G-protein signalling. This receptor is upregulated in numerous cancers making it a potential drug target. Here we collected over 100 distinct structural probes from radiolytic footprinting, disulfide trapping, and mutagenesis to map the structures of ACKR3:CXCL12 and ACKR3:small-molecule complexes, including dynamic regions that proved unresolvable by X-ray crystallography in homologous receptors. The data are integrated with molecular modelling to produce complete and cohesive experimentally driven models that confirm and expand on the existing knowledge of the architecture of receptor:chemokine and receptor:small-molecule complexes. Additionally, we detected and characterized ligand-induced conformational changes in the transmembrane and intracellular regions of ACKR3 that elucidate fundamental structural elements of agonism in this atypical receptor.

Date: 2017
References: Add references at CitEc
Citations:

Downloads: (external link)
https://www.nature.com/articles/ncomms14135 Abstract (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:nat:natcom:v:8:y:2017:i:1:d:10.1038_ncomms14135

Ordering information: This journal article can be ordered from
https://www.nature.com/ncomms/

DOI: 10.1038/ncomms14135

Access Statistics for this article

Nature Communications is currently edited by Nathalie Le Bot, Enda Bergin and Fiona Gillespie

More articles in Nature Communications from Nature
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().